Month: March 2013

Author reply

We thank Hong et al for their comments regarding our manuscript and would like to address several important issues that they raise. The focus of our paper was specifically to study keratoplasty among patients with corneal endothelial disease (CED). Exp…

Author reply

We thank Hong et al for their interest in our paper “Shifting Trends in Bacterial Keratitis in Toronto, an 11 Year Review.” In our paper, we reviewed the microbiology records of 1701 consecutive corneal scrapings; our main findings were a significa…

Bacterial Keratitis in Shanghai

The recent report by Lichtinger et al describing the clinical characteristics of bacterial keratitis isolates over a 11-year period within a Toronto institution raised our interest. Although we found several previous studies about the distribution, cur…

Author reply

We appreciate the comments of Dr. Mamalis. We were unaware of the disagreements that the American Society of Cataract and Refractive Surgery (ASCRS) TASS force had with the Food and Drug Administration’s.

Erratum

With apologies from the publishers, the final authorship in the article entitled, “Prevalence of Glaucoma in a Rural Northern China Adult Population: A Population- based Survey in Kailu County, Inner Mongolia” by Wulian Song, MD, Li Shan, MD, Fang …

This Issue At A Glance

治疗角膜内皮疾病时, 角膜内皮移植手术 (DSEK) 相比传统的全层穿透性角膜移植术 (PK) 昂贵, 然而 Bose 等人 (p. 464) 发现, 从成本效益的角度看, DSEK 应是二者中的首选. 该研究举例, 假设给予固定

A Simple Vista en Este Número

Aunque la queratoplastia endotelial con denudamiento de la Descemet (DSEK) es más costosa que la queratoplastia penetrante (PK) de grosor completo tradicional para la enfermedad endotelial, Bose y otros (p. 464) determinaron que la DSEK debe ser la al…

This Issue At A Glance

Although Descemet’s stripping endothelial keratoplasty (DSEK) is more expensive to perform compared to the traditional full-thickness penetrating keratoplasty (PK) for endothelial disease, Bose et al (p. 464) found that DSEK should be the preferred tre…

Author reply

The FDA acknowledges the extensive work performed by professional eye organizations, including the American Society of Cataract and Refractive Surgery (ASCRS), and Dr. Mamalis in combating Toxic Anterior Segment Syndrome (TASS) outbreaks.